Beiträge

Methods behind oncolytic virus-based DC vaccines in cancer: Toward a multiphase combined treatment strategy for Glioblastoma (GBM) patients

Dendritic cell vaccination for glioblastoma multiforme patients: has a new milestone been reached?

The Application of Evidence-Based Medicine in Individualized Medicine

Individualized Multimodal Immunotherapy for Adults with IDH1 Wild-Type GBM: A Single Institute Experience

Poster presentation at the annual meeting of the Association for Cancer Immunotherapy

Poster presentation at the International Symposium on Pediatric Neuro-Oncology

Synergy between TMZ and individualized multimodal immunotherapy to improve overall survival of IDH1 wild-type MGMT promoter-unmethylated GBM patients

Stem cells-derived natural killer cells for cancer immunotherapy: current protocols, feasibility, and benefits of ex vivo generated natural killer cells in treatment of advanced solid tumors

Randomized Controlled Immunotherapy Clinical Trials for GBM Challenged

Evidence-Based Medicine in Oncology: Commercial Versus Patient Benefit